Assessment of parameters of lung ventilation during 6-minute walk test in patients with COPD.

Posted on 26 February 2016, Scientific, Spiropalm

Assessment of parameters of lung ventilation during 6-minute walk test in patients with COPD.

The importance of measuring ventilation during the Six Minute Walk test in COPD patients has been confirmed in a study presented during the European Respiratory Society Congress in 2015 and published in the European Respiratory Journal.

Ventilatory analysis during 6MWT gives relevant information about exercise limitation in COPD.

Posted on 04 February 2016, Scientific, Spiropalm

Ventilatory analysis during 6MWT gives relevant information about exercise limitation in COPD.

A new poster was presented during the 2015 ERS Conference and then published in the European Respiratory Journal, highlighting the importance of ventilatory analysis during the Six Minute Walk Test (6MWT) in COPD patients.

6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias.

Posted on 15 January 2015, Scientific, Spiropalm

6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias.

An interesting poster presented during the 2014 ERS Congress features the importance of the six minute walk test with Spiropalm 6MWT in patients affected by fibrotic idiopathic interstitial pneumonias.

COSMED and Spiropalm 6MWT winners of ERS Product of Outstanding Interest 2013.

Posted on 24 September 2013, English, COSMED News, Company, Italiano, Deutsch, French, Spiropalm

Omnia Spirometry Module

COSMED Spiropalm 6MWT handheld spirometer won the 2013 Product of Outstanding Interest (POINT) Award from the European Respiratory Society (ERS) during the ERS Congress in Barcelona (Spain).

The six-minute walking test accompanied by pulse oximetry and ventilation assessment in patients with pulmonary arterial hypertension.

Posted on 23 September 2013, Scientific, Spiropalm

spirometry and six minute walk test

A new study was presented during 2013 ERS Congress with the aim was to evaluate exercise capacity, oxygen desaturation and minute ventilation (VE) during six-minute walking test (6MWT) in patients with pulmonary arterial hypertension (PAH).